When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A multiple sclerosis specialist shares insights on quiet progression, and discusses research and treatments for MS activity without relapses.

Edmondson has been the lead investigator on or participated on research teams behind more than 50 clinical studies showing ...

Jenna Borthwick, from the Scottish Borders, has shared the signs and symptoms that she had a huge tumour in the left side of ...

Under the new spending bill, the nation’s largest abortion provider would have to stop offering abortion in some states or ...

Willy Weidenhofer's hand-knitted trauma teddies have been handed out to hundreds of children in ambulances or the emergency ...

Woodland View is to close a secure unit for people with complex learning disabilities after it was found to be 'no longer ...

And, their performances would also conclude the highly successful, two-weekend runs of all 12 plays that made this year’s ...

An aesthetic beautician left one woman fighting for her life and several others seriously ill in hospital after injecting ...

The initiative targets 3,000 individuals from the B40 income bracket over the next two years, extending screenings across ...

Speculation about the futures Sir Keir Starmer and Rachel Reeves threatens to overshadow the announcement on improving ...

Bielekova, B. et al. Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta. Proc. Natl Acad. Sci. USA 101, 8705–8708 (2004).